Cargando…
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries. Essential to this achievement was the dramatic reduction in antiretroviral prices, a result of global political mobilization that cleared the w...
Autores principales: | Hoen, Ellen 't, Berger, Jonathan, Calmy, Alexandra, Moon, Suerie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078828/ https://www.ncbi.nlm.nih.gov/pubmed/21439089 http://dx.doi.org/10.1186/1758-2652-14-15 |
Ejemplares similares
-
Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
por: Moon, Suerie, et al.
Publicado: (2012) -
Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
por: Waning, Brenda, et al.
Publicado: (2010) -
Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP)
por: Juneja, Sandeep, et al.
Publicado: (2017) -
The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good
por: Bermudez, Jorge, et al.
Publicado: (2010) -
Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.
por: ‘t Hoen, Ellen F. M., et al.
Publicado: (2018)